Profiel
Christine Guillen is the founder and currently serves as the Chief Executive Officer & Director of ElsaLys Biotech SAS, a company she founded in 2013.
Prior to founding ElsaLys Biotech SAS, she held the position of Director-Project Management at EUSA Pharma SAS from 2005 to 2007 and Head-External Programs at Transgene SA from 2007 to 2013.
Actieve functies van Christine Guillen
| Bedrijven | Functie | Begin |
|---|---|---|
| ELSALYS BIOTECH | Founder | 01-01-2013 |
Eerdere bekende functies van Christine Guillen
| Bedrijven | Functie | Einde |
|---|---|---|
| TRANSGENE | Corporate Officer/Principal | 01-01-2013 |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Corporate Officer/Principal | 01-10-2007 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Health Technology |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
